| Angiotensin II type 2 receptor vasoactivity in internal mammary arteries of patients with coronary artery disease. | |
| | |
MedLine Citation:
|
PMID: 18049304 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Several animal studies suggested that the angiotensin II type 2 (AT2) receptor subtype mediates vasodilation, yet the results in human arteries are less well described and more inconsistent. Therefore, we evaluated the role of the AT2 receptor stimulation on the vasotonus of human internal mammary arteries. METHODS: Internal mammary arteries were obtained from 50 patients undergoing coronary bypass surgery. The expression of angiotensin II type 1 (AT1) receptor and AT2 receptor mRNA was determined by using real-time polymerase chain reaction. In addition, angiotensin II and CGP42112A concentration-response curves (concentration range: 10(-10) M to 10(-6) M) were constructed in absence or presence of candesartan (10(-5) M) and/or the AT2 receptor-antagonist PD-123319 (10(-6) M) and/or the alpha receptor antagonist phentolamine. RESULTS: Both AT1 and AT2 receptor protein and mRNA were detected, and higher AT2 receptor mRNA expression levels were associated with increased contractile response to angiotensin II. Angiotensin II caused vasoconstriction up to 41.1 +/- 6.5% of the maximal response to phenylephrine, and PD123319 significantly reduced this response (28.6 +/- 9.6%, P < 0.001). Candesartan completely blocked the angiotensin II-mediated response (1.4 +/- 3.1%, P < 0.001 versus control), and additional blockade of the AT2 receptor with PD123319 did not change this effect (1.8 +/- 5.1%). Phentolamine (10(-5) M) caused attenuation and rightward shift of the angiotensin II concentration response curves. The AT2 receptor agonist CGP42112A did not induce a significant response. CONCLUSION: Although AT2 receptor mRNA is present in human internal mammary arteries, AT2 receptor stimulation does not mediate vasodilation in these arteries. |
| | |
Authors:
|
R M A van de Wal; P van der Harst; L J Wagenaar; S Wassmann; W J Morshuis; G Nickenig; H Buikema; H W M Plokker; D J van Veldhuisen; W H van Gilst; A A Voors |
Related Documents
:
|
8895394 - Immunolocalization of rat thromboxane receptor in the kidney. 8772564 - Down-regulation of angiotensin at1 receptor by progesterone in human placenta. 8726684 - Characterization and regulation of angiotensin ii receptors in rat adipose tissue. angi... 12570014 - New insights in insurmountable antagonism. 21745474 - Nuclear receptors: t(h)17 cell control from within. 17132494 - Phenotype changes of fut8 knockout mouse: core fucosylation is crucial for the function... |
Publication Detail:
|
Type: In Vitro; Journal Article |
Journal Detail:
|
Title: Journal of cardiovascular pharmacology Volume: 50 ISSN: 0160-2446 ISO Abbreviation: J. Cardiovasc. Pharmacol. Publication Date: 2007 Oct |
Date Detail:
|
Created Date: 2007-11-30 Completed Date: 2008-02-05 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7902492 Medline TA: J Cardiovasc Pharmacol Country: United States |
Other Details:
|
Languages: eng Pagination: 372-9 Citation Subset: IM |
Affiliation:
|
Department of Cardiology, St. Antonius Hospital, Koekoekslaan 1, 3435 CM Nieuwegein, The Netherlands. r.wal@antonius.net |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Acetylcholine
/
pharmacology Adrenergic alpha-Antagonists / pharmacology Adult Aged Aged, 80 and over Angiotensin II / pharmacology Angiotensin II Type 1 Receptor Blockers / pharmacology Benzimidazoles / pharmacology Coronary Artery Disease / physiopathology* Female Gene Expression / drug effects Humans Imidazoles / pharmacology Male Mammary Arteries / drug effects, physiology* Middle Aged Oligopeptides / pharmacology Phentolamine / pharmacology Phenylephrine / pharmacology Pyridines / pharmacology Receptor, Angiotensin, Type 1 / genetics, metabolism, physiology Receptor, Angiotensin, Type 2 / genetics, metabolism, physiology* Sodium Nitrite / pharmacology Tetrazoles / pharmacology Vasoconstrictor Agents / pharmacology Vasodilation / drug effects, physiology* Vasodilator Agents / pharmacology |
| Chemical | |
Reg. No./Substance:
|
0/Adrenergic alpha-Antagonists; 0/Angiotensin II Type 1 Receptor Blockers; 0/Benzimidazoles; 0/Imidazoles; 0/Oligopeptides; 0/Pyridines; 0/Receptor, Angiotensin, Type 1; 0/Receptor, Angiotensin, Type 2; 0/Tetrazoles; 0/Vasoconstrictor Agents; 0/Vasodilator Agents; 11128-99-7/Angiotensin II; 127060-75-7/CGP 42112A; 130663-39-7/PD 123319; 139481-59-7/candesartan; 50-60-2/Phentolamine; 51-84-3/Acetylcholine; 59-42-7/Phenylephrine; 7632-00-0/Sodium Nitrite |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Telmisartan improves endothelial function in patients with essential hypertension.
Next Document: Tamoxifen stimulates calcium entry into human platelets.